FDA approves dissolving stent for endovascular treatment of peripheral artery disease below knee Dr. Kamal Kant Kohli2 May 2024 8:45 AM ISTThe US Food and Drug Administration has approved Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the...
FFR-guided complete revascularization fails to improve outcomes in patients with MI: NEJM Medha Baranwal25 April 2024 10:00 AM ISTSweden: Fractional flow reserve (FFR)-guided complete revascularization does not result in better outcomes compared with primary percutaneous coronary...
Revascularization enhances quality of life for patients with chronic limb threatening ischemia: NEJM Dr. Kamal Kant Kohli11 April 2024 6:30 PM ISTResearchers have found in a new study that revascularization may restores sufficient blood flow back into the legs and significantly improves...
Beta-blocker use after MI and preserved ejection fraction offers no benefit: REDUCE-AMI trial Medha Baranwal10 April 2024 9:30 PM ISTSweden: Findings from the REDUCE-AMI published in The New England Journal of Medicine have shown no benefit of beta-blockers in revascularized...
Experimental drug Olezarsen may reduce hypertriglyceridemia in high-risk patients: NEJM Dr. Kamal Kant Kohli10 April 2024 8:45 AM ISTHypertriglyceridemia, or high levels of lipids (fats) in the blood, increases the risk of heart attack, stroke and acute pancreatitis. Currently...
Empagliflozin fails to reduce HF hospitalizations, deaths after acute MI: EMPACT-MI Medha Baranwal9 April 2024 10:00 AM ISTUSA: Treatment with empagliflozin did not lead to a significantly reduced risk of first hospitalization for heart failure (HF) or death from any cause...
Primary care strategy did not reduce hospitalizations at one year in kidney-dysfunction triad: ICD-Pieces study Dr Kartikeya Kohli5 April 2024 2:00 AM ISTUSA: Using an electronic health record (EHR)-based algorithm plus practice facilitators embedded in primary care clinics did not reduce...
Health Bulletin 28/ March/ 2024 Roshni Dhar28 March 2024 5:16 PM ISTHere are the top health news for the day:Delhi Govt mandates CCTV recording of viva exams to safeguard female medicosPrioritising the safety of female...
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence: NEJM Dr. Kamal Kant Kohli26 March 2024 11:15 PM ISTA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2...
Prenatal exposure to antiseizure medication topiramate may not increase risk of autism spectrum disorder among kids: NEJM Dr. Kamal Kant Kohli22 March 2024 12:45 AM ISTTopiramate is an antiseizure medication prescribed to treat epilepsy as well as migraines and bipolar disorder.Researchers at Harvard T.H. Chan...
Experimental gene therapy for giant axonal neuropathy promising in clinical trial: NEJM Dr. Kamal Kant Kohli21 March 2024 8:45 PM ISTAn investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well...
CRT Defibrillator bests IC Defibrillator for increasing survival in HF patients with wide QRS complex: NEJM Medha Baranwal15 March 2024 10:15 PM ISTUSA: Long-term results of the RAFT trial showed survival benefits associated with receipt of cardiac resynchronization therapy defibrillator (CRT-D)...
